Company Filing History:
Years Active: 2008-2021
Title: The Innovations of Daniel Patterson
Introduction
Daniel Patterson is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on crystalline compounds and their applications in treating diseases.
Latest Patents
Patterson's latest patents include a crystalline spirocyclic compound and a dosage form containing it. One of his notable inventions is a method for using this compound in the treatment of diseases. The crystalline compound, specifically (S)-ethyl 8-(2-amino-6-((R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-2,8-diazaspiro[4.5]decane-3-carboxylate, exhibits a characteristic XRPD pattern with a peak at 19.05±0.20 (° 2θ). Additionally, he has developed a pharmaceutical composition containing this compound, along with a dosage form that includes one or more pharmaceutically acceptable excipients. Furthermore, Patterson has created methods for crystallizing and recrystallizing the compound, as well as methods for treating or preventing diseases using it.
Career Highlights
Throughout his career, Daniel Patterson has worked with notable companies such as SmithKline Beecham Corporation and Altavant Sciences GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Patterson has collaborated with several professionals in his field, including David Igo and Paul R. Johnson. These partnerships have likely enhanced his research and development efforts.
Conclusion
Daniel Patterson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of diseases and the development of new pharmaceutical compounds.